---
title: "标记临床研究 (XOMA.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/XOMA.US/norm.md"
symbol: "XOMA.US"
name: "标记临床研究"
parent: "https://longbridge.com/zh-CN/quote/XOMA.US.md"
datetime: "2026-05-21T01:56:59.943Z"
locales:
  - [en](https://longbridge.com/en/quote/XOMA.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/XOMA.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/XOMA.US/norm.md)
---

# 标记临床研究 (XOMA.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | 0.1730 | 0.2586 | 0.6991 | 0.4405 | 0.0562 |
| ROE | 9.60% | 15.48% | 44.83% | 28.14% | 3.85% |
| 营业收入 | 12.32M | 13.76M | 9.35M | 13.13M | 15.91M |
| 净利润 | 2.12M | 3.32M | 8.98M | 5.52M | 705000.00 |
| 营业利润 | -480000.00 | 2.18M | -1.33M | 4.60M | 5.93M |
| 毛利率 | 99.60% | 97.96% | 99.26% | 99.47% | 91.87% |
| 净利率 | 36.25% | 44.36% | 150.26% | 70.01% | 14.88% |
| 利润含金量 | -7.84% | -39.67% | - | 71.14% | 269.75% |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 271.86M | 272.70M | 263.15M | 223.46M | 212.75M |
| 权益乘数 | 2.41 | 2.62 | 2.44 | 2.42 | 2.51 |
| 每股净资产 | 7.79 | 7.07 | 7.14 | 6.00 | 7.08 |
| 资产周转率 | 0.2004 | 0.2111 | 0.1937 | 0.1926 | 0.1986 |
| 现金及短投 | 86.09M | 83.29M | 46.71M | 83.86M | 92.65M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 257000.00 | 277000.00 | 296000.00 | 314000.00 | 333000.00 |
| 净债务 | 38.64M | 48.27M | 85.20M | 30.72M | 21.80M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | 6.12M | -5.50M | -296000.00 | 6.47M | 2.20M |
| 投资现金流 | 6.55M | 19.35M | 58.21M | -19.98M | -6.69M |
| 融资现金流 | -7.64M | -10.69M | -5.85M | -3.03M | -6.89M |
| 自由现金流 | 1.16M | 44.57M | -39.12M | -12.89M | -36375.00 |
| 现金流充裕率 | 78.32% | -402.12% | -4.47% | 393.55% | 34.16% |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | - | - | - | - | - |